Dr. Prahlad Singh is President and Chief Executive Officer of PerkinElmer, Inc. Prior to this appointment in December of 2019, Dr. Singh served as President and Chief Operating Officer since January 2019 and before that was President of the Diagnostics business from 2014 to 2019.
Prior to joining PerkinElmer, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Dr. Singh has more than 25 years of leadership experience with global innovators in healthcare technology and has had research work result in several issued patents and publications in peer reviewed journals. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. He also currently serves on the Board of Directors of the Analytical, Life Science & Diagnostics Association (ALDA); and is a member of the Massachusetts General Hospital President's Council.
Jamey Mock joined PerkinElmer in May of 2018 as Senior Vice President and Chief Financial Officer.
Prior to joining the Company, Mr. Mock spent nearly 20 years at General Electric Company (GE) where he held various leadership roles. Most recently, he served as Vice President, Corporate Audit Staff, working globally across GE’s businesses on controllership reviews and operational excellence projects. Before that, he served in a number of progressively senior roles in complex large, global businesses based in the United States and overseas. Mr. Mock holds a B.A. in Economics from St. Lawrence University.
Miriame Victor is Senior Vice President and Chief Commercial Officer at PerkinElmer, Inc. Since joining the Company in 2014, Ms. Victor has held a number of leadership positions, most recently serving as Vice President and General Manager of the EMEAI (Europe, Middle East, Africa, India) region prior to assuming her current role.
Before joining PerkinElmer, Ms. Victor held various commercial leadership positions at MSD, Novartis and GE Healthcare. She received her B.S. in Clinical Pharmacy from Cairo University and her M.B.A. in Strategic Management from Arab Academy for Science, Technology and Maritime Transport. Additionally, Ms. Victor is a graduate of the Experienced Commercial Leadership Program at GE and a certified Six Sigma Black Belt.
Dr. Alan Fletcher is Senior Vice President, Life Sciences for PerkinElmer, Inc. Dr. Fletcher joined PerkinElmer in 2008 as the head of the Life Sciences business development team. From 2008-2016, he held a variety of progressive leadership positions at the Company, including regional leader of PerkinElmer’s Life Sciences business in the Asia-Pacific region.
Before joining PerkinElmer, Dr. Fletcher held several leadership positions at GE Healthcare Life Sciences as well as Merck & Co. in the United Kingdom. With more than 30 years of leadership experience in the life sciences industry, Dr. Fletcher has been published in more than 30 peer-reviewed publications. He holds a B.S. in Biochemistry from Surrey University in the U.K., and a Ph.D in Biochemical Pharmacology from the University of London.
Amar Kamath is Vice President and General Manager of Diagnostics at PerkinElmer, Inc. Prior to this appointment in May of 2021, Mr. Kamath served as the Vice President and General Manager of PerkinElmer’s Vanadis business, a role he held since June of 2019.
With a strong background in women’s health, oncology, immunology and infectious disease, Mr. Kamath held a variety of sales, marketing and business development leadership positions at several commercial clinical diagnostics laboratories before joining PerkinElmer. Most recently, he served as the Senior Vice President, Commercial at Natera. Mr. Kamath holds a B.E. in Mechanical Engineering from the N.M.A.M. Institute of Technology and an M.B.A. from Illinois State University.
Dr. Karen Madden is Senior Vice President and Chief Innovation Officer at PerkinElmer, Inc. Before assuming her current role, Dr. Madden was President of PerkinElmer’s Informatics business and prior to that, held various leadership and development positions within the Company’s Diagnostics and pre-existing Emerging Technologies businesses.
Dr. Madden joined PerkinElmer in 2010 through the acquisition of VisEn, a molecular imaging company where she served as Vice President of Business and Corporate Development. Prior to that role, she served as a Director at Feinstein Kean Healthcare and Kendall Strategies. Dr. Madden holds a B.A. in Chemistry from Boston University, a M.S. in Chemistry from the University of Pennsylvania and a Ph.D. in Chemistry from Rutgers University.
Before joining PerkinElmer in 2015, he held various global leadership positions over the course of 26 years at GE, in the United States and abroad. Prior to GE, Mr. Vildzius served four years as a commissioned officer in the United States Air Force; during his service, he was promoted to the rank of Captain and was awarded the U.S. Air Force Commendation Medal. Mr. Vildzius holds a B.S. in Mechanical Engineering from Rensselaer Polytechnic University and a M.S. in Mechanical Engineering from Union College. He is also a graduate of the U.S. Air Force ROTC Scholarship Program and the U.S. Air Force Squadron Officer School, and is a certified Six Sigma Black Belt.